中国危重病急救医学
中國危重病急救醫學
중국위중병급구의학
CHINESE CRITICAL CARE MEDICINE
2010年
1期
16-19
,共4页
蒋忠胜%温小凤%张鹏%陈念%柯柳%李敏基%覃川%韦静彬
蔣忠勝%溫小鳳%張鵬%陳唸%柯柳%李敏基%覃川%韋靜彬
장충성%온소봉%장붕%진념%가류%리민기%담천%위정빈
肝移植标准数学模型评分%Child-Turcotte-Pugh评分%肝衰竭%预后评价
肝移植標準數學模型評分%Child-Turcotte-Pugh評分%肝衰竭%預後評價
간이식표준수학모형평분%Child-Turcotte-Pugh평분%간쇠갈%예후평개
Liver transplantation standard mathematical model score%Child-Tureotte-Pugh score%Liver failure%Evaluation of the prognosis
目的 比较肝移植标准数学模型(LTS)评分和Child-Turcotte-Pugh(CTP)评分对肝衰竭患者预后的临床评估价值.方法 回顾性分析2004年1月至2008年12月入住本院150例肝衰竭患者的病历资料,按患者入院后90 d的生存情况分为生存组(48例)和死亡组(102例).收集患者入院24 h内的LTS评分和CTP评分系统所需要的相关资料,分别计算LTS评分和CTP评分,比较生存组和死亡组的LTS评分和CTP评分.采用Spearman等级相关分析法分析LTS评分和CTP评分与肝衰竭预后的相关性;采用受试者工作特征曲线(ROC曲线)下面积(AUC)比较两个评分系统的预测能力.结果 生存组LTS评分[(38.88±4.27)分]和CTP评分[(11.25±0.97)分]均显著低于死亡组[LTS评分:(52.63±10.65)分,CTP评分:(12.18±1.22)分,均P<0.01].LTS评分与肝衰竭预后的秩相关系数(r_s=0.651,P<0.01)高于CTP评分(r_s=0.366,P<0.01).LTS评分的AUC为0.897,敏感性(SN)为76.52%,特异性(SP)为91.18%,阳性预测值(PV+)为94.39%,阴性预测值(PV-)为66.67%,约登指数为0.677;CTP评分的AUC为0.716,SN为40.91%,SP为92.65%,PV+为91.53%,PV-为44.68%,约登指数为0.336.结论 LTS评分在评估肝衰竭患者预后的临床价值优于CTP评分.
目的 比較肝移植標準數學模型(LTS)評分和Child-Turcotte-Pugh(CTP)評分對肝衰竭患者預後的臨床評估價值.方法 迴顧性分析2004年1月至2008年12月入住本院150例肝衰竭患者的病歷資料,按患者入院後90 d的生存情況分為生存組(48例)和死亡組(102例).收集患者入院24 h內的LTS評分和CTP評分繫統所需要的相關資料,分彆計算LTS評分和CTP評分,比較生存組和死亡組的LTS評分和CTP評分.採用Spearman等級相關分析法分析LTS評分和CTP評分與肝衰竭預後的相關性;採用受試者工作特徵麯線(ROC麯線)下麵積(AUC)比較兩箇評分繫統的預測能力.結果 生存組LTS評分[(38.88±4.27)分]和CTP評分[(11.25±0.97)分]均顯著低于死亡組[LTS評分:(52.63±10.65)分,CTP評分:(12.18±1.22)分,均P<0.01].LTS評分與肝衰竭預後的秩相關繫數(r_s=0.651,P<0.01)高于CTP評分(r_s=0.366,P<0.01).LTS評分的AUC為0.897,敏感性(SN)為76.52%,特異性(SP)為91.18%,暘性預測值(PV+)為94.39%,陰性預測值(PV-)為66.67%,約登指數為0.677;CTP評分的AUC為0.716,SN為40.91%,SP為92.65%,PV+為91.53%,PV-為44.68%,約登指數為0.336.結論 LTS評分在評估肝衰竭患者預後的臨床價值優于CTP評分.
목적 비교간이식표준수학모형(LTS)평분화Child-Turcotte-Pugh(CTP)평분대간쇠갈환자예후적림상평고개치.방법 회고성분석2004년1월지2008년12월입주본원150례간쇠갈환자적병력자료,안환자입원후90 d적생존정황분위생존조(48례)화사망조(102례).수집환자입원24 h내적LTS평분화CTP평분계통소수요적상관자료,분별계산LTS평분화CTP평분,비교생존조화사망조적LTS평분화CTP평분.채용Spearman등급상관분석법분석LTS평분화CTP평분여간쇠갈예후적상관성;채용수시자공작특정곡선(ROC곡선)하면적(AUC)비교량개평분계통적예측능력.결과 생존조LTS평분[(38.88±4.27)분]화CTP평분[(11.25±0.97)분]균현저저우사망조[LTS평분:(52.63±10.65)분,CTP평분:(12.18±1.22)분,균P<0.01].LTS평분여간쇠갈예후적질상관계수(r_s=0.651,P<0.01)고우CTP평분(r_s=0.366,P<0.01).LTS평분적AUC위0.897,민감성(SN)위76.52%,특이성(SP)위91.18%,양성예측치(PV+)위94.39%,음성예측치(PV-)위66.67%,약등지수위0.677;CTP평분적AUC위0.716,SN위40.91%,SP위92.65%,PV+위91.53%,PV-위44.68%,약등지수위0.336.결론 LTS평분재평고간쇠갈환자예후적림상개치우우CTP평분.
Objective To compare the clinical value of the liver transplantation standard (LTS)mathematical model score and Child-Turcotte-Pugh (CTP) score in evaluating the prognosis of liver failure.Methods The clinical data of 150 liver failure patients were analyzed retrospectively.All the patients who were admitted from January 2004 to December 2008 were divided into survival group (n=48) and death group (n=102) in regard to their 90-day survival after their admission.LTS score and CTP score were calculated according to their respective clinical data within 24 hours after their admission.Comparison between LTS score and CTP score was conducted respectively between the survival group and death group.The correlation between LTS score/CTP score and the prognosis of liver failure was made by Spearman rank correlation.The ability of LTS score and CTP score to predict the outcome of liver failure was compared with the receiver operating characteristic (ROC) curve.Results The LTS score and CTP score of survival group were 38.88±4.27 and 11.25±0.97,respectively,which were lower than those of death group (52.63±10.65 and 12.18±1.22,both P<0.01).The correlation coefficient of LTS score and the prognosis of liver failure (r_s=0.651,P<0.01) was higher than that of CTP score (r_s=0.366,P<0.01).The area under ROC curve (AUC) of LTS score was 0.897,sensitivity (SN) was 76.52%,specificity (SP) was 91.18%,positive predictive value (PV+) was 94.39%,negative predictive value (PV-) was 66.67 %,and Youden index was 0.677,respectively.The AUC of CTP score was 0.716,those of SN,SP,PV+,PV- and Youden index were 40.91%,92.65%,91.53%,44.68% and 0.336,respectively.Conclusion The LTS score is better than the CTP score in evaluating the prognosis of liver failure.